Ionis Pharmaceuticals Inc (NAS:IONS)
$ 35.91 -0.42 (-1.16%) Market Cap: 5.74 Bil Enterprise Value: 4.73 Bil PE Ratio: 0 PB Ratio: 8.65 GF Score: 40/100

Ionis Pharmaceuticals Inc at Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days (Virtual) Transcript

Apr 04, 2023 / 02:45PM GMT
Release Date Price: $35.35
Operator

You may begin.

Debjit D. Chattopadhyay
Guggenheim Securities, LLC, Research Division - Senior Analyst of Biotechnology

All right. Good morning, and thank you for joining us on Guggenheim's Genomic Medicine and Rare Disease conference, day 2. This is the fifth iteration. I am Debjit and I'm one of the covering analysts at Guggenheim. My privilege to welcome Ionis Pharmaceuticals Executive Vice President of Research, Eric Swayze. Good morning, Eric. Thank you for your time today.

Eric E. Swayze
Ionis Pharmaceuticals, Inc. - EVP of Research

Good morning, and thanks for having me on your show. Appreciate being here.

Questions & Answers

Debjit D. Chattopadhyay
Guggenheim Securities, LLC, Research Division - Senior Analyst of Biotechnology

Well not much of a show, but let's get on with the Q&A then. I mean, obviously, given the depth and breadth of the pipeline and the recent positive - [go over] some panel votes, any key programs you would like -- or the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot